Home > Insider Trading > Filing (0001209191-20-056745)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1439725	Biodesix Inc	BDSX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1134554	Hany Massarany	2970 Wilderness Place, Suite 100 Boulder CO 80301		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-10-30	7,500	$18.00	7,500	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to buy)	Acquisiton	2020-07-01	35,158	$0.00	35,158	$6.83
Common Stock	Restricted Stock Units	Acquisiton	2020-07-01	26,368	$0.00	26,368	$6.83

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
35,158		2030-06-30	No	4	A	Direct
26,368		2030-06-30	No	4	A	Direct

Footnotes

This transaction occurred prior to the Issuer's initial public offering and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3.
This option vests in 12 successive, equal monthly installments measured from July 1, 2020.
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer Common Stock ("Common Stock"). These RSUs vest 40% on July 1, 2022, and the remaining 60% in 36 successive, equal monthly installments measured from July 1, 2022.